BioLineRx (BLRX) Gross Profit (2024 - 2026)
BioLineRx (BLRX) posted Gross Profit of $235,000 for the quarter ended Jun 30, 2026, up 1.3% from $232,000 a year earlier but down 38.5% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Gross Profit (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at BioLineRx was $1.11 million, down 89.1% year-over-year; for the year ended Dec 31, 2025, it was $950,000, down 95.2% from the prior year.
- In prior years, BioLineRx's Gross Profit was $19.68 million in the year ended Dec 31, 2024 and $1.11 million in the year ended Dec 31, 2023.
- Quarterly Gross Profit has run from a low of $154,000 in the quarter ended Dec 31, 2025 to a high of $5.66 million in the quarter ended Dec 31, 2024 over five years.
- On a year-over-year basis, Gross Profit increased in two of the last six quarters, with an average decline of 50.9%.
- According to Business Quant data, Gross Profit for the three prior quarters was $382,000 (quarter ended Mar 31, 2026), $154,000 (quarter ended Dec 31, 2025) and $343,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 235,000.00 |
| Mar 31, 2026 | 382,000.00 |
| Dec 31, 2025 | 154,000.00 |
| Sep 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 5.66 Mn |
| Sep 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | 5.40 Mn |
API Access
BioLineRx Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();